GUTS Q3 2024 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14,000-61.1% YoY

Gross Profit

$7,00050.0% margin

Operating Income

-$24M-169957.1% margin

Net Income

-$23M-165521.4% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

-67.4%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$127M

Total Liabilities

$77M

Stockholders' Equity

$50M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14,000	$36,000	-61.1%
Gross Profit	$7,000	-$73,000	+109.6%
Operating Income	-$24M	-$14M	-71.5%
Net Income	-$23M	-$16M	-47.2%